Levitaid A/S is a Danish A/S based in København K, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2012, the company has 0 employees and reported revenue of DKK 21.0k in its latest annual filing.
| Revenue | 0M DKK | -101% |
| EBITDA | -0.8M DKK | +67% |
| Net profit | -1.8M DKK | +36% |
| Total assets | 0.1M DKK | -94% |
| Equity | -4.2M DKK | -78% |
| Employees | 0 | — |
In its most recent annual report (2014), Levitaid A/S reported revenue of DKK 21.0k. The figures on this page draw on 2 annual filings covering 2013 to 2014. The bottom line showed a net loss of DKK 1.8m, and the EBITDA margin stood at -3,857.1%.
At the end of 2014, current assets covered short-term debt 0 times.
| Item | 2014 | 2013 |
|---|---|---|
| Revenue | 21 | -1,619 |
| Staff expenses | -297 | -832 |
| EBITDA | -810 | -2,451 |
| Depreciation & amort. | -830 | 289 |
| EBIT | -1,640 | -2,740 |
| Net financials | -186 | -116 |
| Profit before tax | -1,826 | -2,856 |
| Tax | -0 | -0 |
| Net profit | -1,826 | -2,856 |
| Item | 2014 | 2013 |
|---|---|---|
| Total assets | 54 | 859 |
| Equity | -4,182 | -2,356 |
| Long-term debt | 0 | 0 |
| Short-term debt | 4,236 | 3,215 |
| Total debt | 4,236 | 3,215 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of total assets — the return generated on the capital employed.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|
CF Management | Management | 2012 – 2015 |
| Name | Role | Member since |
|---|
CF Board of Directors | Board of Directors | 2012 – 2015 |
EM Board of Directors | Board of Directors | 2012 – 2012 |
IG Chairman | Chairman | 2012 – 2015 |
NF Board of Directors | Board of Directors | 2012 – 2015 |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Inge Grønvold | Chairman | 16 companiesMany roles |
| Eskil Morten Risby Nielsen | Board of Directors | 5 companies |
| Niels Fink-Jensen | Board of Directors | 1 company |